Αρχειοθήκη ιστολογίου

Τρίτη 20 Ιουνίου 2017

Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer

Condition:   Pancreatic Cancer Interventions:   Drug: Cyclophosphamide;   Drug: Nivolumab;   Drug: Ipilimumab;   Drug: GVAX Pancreas Vaccine;   Drug: CRS-207;   Drug: CRS-207 Sponsors:   Sidney Kimmel Comprehensive Cancer Center;   Aduro Biotech, Inc.;   Bristol-Myers Squibb Not yet recruiting - verified June 2017 (Source: ClinicalTrials.gov)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2sT7zz6
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader